ask="1.84"
ask_size="300"
average_daily_volume="718990"
bid="1.61"
bid_size="500"
book_value="1.07"
change="-0.11"
change_from_200_day_moving_average="-0.51"
change_from_50_day_moving_average="0.15"
change_from_52_week_high="-4.14"
change_From_52_week_low="1.62"
change_in_percent="-6.33%"
close="1.63"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.01"
ebitda="-16.58M"
eps_estimate_current_year="-0.92"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-0.28"
ex_dividend_date="N/A"
float_shares="5773000"
high="1.82"
high_52_weeks="5.77"
last_trade_date="2/6/2017"
last_trade_price="1.63"
last_trade_size="100"
last_trade_time="3:58pm"
low="1.61"
low_52_weeks="0.01"
market_capitalization="19.05M"
moving_average_200_day="2.14"
moving_average_50_day="1.48"
name="PhaseRx
Inc."
notes="N/A"
one_year_target_price="10.00"
open="1.82"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-23.79%"
percent_change_from_50_day_moving_average="+10.34%"
percent_change_from_52_week_high="-71.74%"
percent_change_from_52_week_low="+15423.81%"
previous_close="1.74"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.63"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="11690000"
short_ratio="0.18"
stock_exchange="NCM"
symbol="PZRX"
volume="66011"
weeks_range_52="0.01 - 5.77"
